A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome

• Meral Beksac,
• Guldane Cengiz Seval,
• Nicholas Kanellias,
• Daniel Coriu,
• Laura Rosiñol,
• Gulsum Ozet,
• Vesselina Goranova-Marinova,
• Ali Unal,
• Jelena Bila,
• Hayri Ozsan,
• Arben Ivanaj,
• Lejla Ibricevic Balić,
• Efstathios Kastritis,
• Joan Bladé,
• Meletios Athanasios Dimopoulos

Affiliations

Meral Beksac

Department of Hematology, School of Medicine, Ankara University, Ankara, Turkey

Guldane Cengiz Seval

Department of Hematology, School of Medicine, Ankara University, Ankara, Turkey

Nicholas Kanellias

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Daniel Coriu

University of Medicine and Pharmacy "Carol Davila", Fundeni Clinical Institute, Bucharest, Romania

Laura Rosiñol

Hospital Clinic, IDIBAPS, Barcelona

Gulsum Ozet

Clinic of Hematology, Ankara Numune Education and Research Hospital, Ankara, Turkey

Vesselina Goranova-Marinova

University Hospital “Sv. Georgi” and Medical University Plovdiv, Plovdiv, Bulgaria

Ali Unal

Department of Hematology, School of Medicine, Erciyes University, Kayseri, Turkey

Jelena Bila

Faculty of Medicine, University of Belgrade, Belgrade, Serbia

Hayri Ozsan

Department of Hematology, School of Medicine, Dokuz Eylul University, Izmir, Turkey

Arben Ivanaj

University of Medicine Tirana, Tirana, Albania

Lejla Ibricevic Balić

Clinical Center of Sarajevo University, Sarajevo, Bosnia and Herzegovina

Efstathios Kastritis

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Joan Bladé

Hospital Clinic, IDIBAPS, Barcelona

Meletios Athanasios Dimopoulos

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece